Intensity Therapeutics, Inc.

NASDAQ: INTS · Healthcare · Biotechnology

PublicHQ Westport, CT · FairfieldCIK 0001567264Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 43DQ —GM —SS 23

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, filing timeliness · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$11.6M

Employees

Market cap

$8.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$11.6M-$11.6M2025

Operating income-$12.0M-$12.0M2025

Total assets$14.1M$14.1M2025

Liabilities$2.2M$2.2M2025

Equity$11.9M$11.9M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Intensity Therapeutics, Inc. earned -$11.6M in FY2025 net income.

Peers · Healthcare

CompuMed, Inc.69B Polarean Imaging plc——SpotLite360 IOT Solutions, Inc.——Kairos Pharma, Ltd.——

Neighbors

Fairfield →

Interactive Brokers Group, Inc.$2.4B74B Booking Holdings Inc.$26.9B79B+United Rentals, Inc.$3.7B78B+EMCOR Group, Inc.$17.0B83B+W. R. Berkley Corporation$555.8M79B+Hubbell Incorporated$5.8B83B+

Key facts

CEOLewis H. Bender

SectorHealthcare

IndustryBiotechnology

HeadquartersWestport, CT

ExchangeNASDAQ: INTS

Employees5

IPO date2023-06-30

Latest filings

8-K2026-06-16 10-Q2026-05-07 8-K2026-05-07 DEF 14A2026-04-30 8-K2026-03-27 10-K2026-03-27 8-K2026-03-23 8-K2026-03-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.